Author

S. M. Weston

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

C. Dillen· 3 shared H. L. Hammond· 3 shared R. M. Johnson· 3 shared A. Chang· 2 shared A. G. Schmidt· 2 shared A. Ozonoff· 2 shared A. Z. Xu· 2 shared B. M. Hauser· 2 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

C. Dillen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivNov 8, 2021

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease

B. J. Davenport, A. Catala, S. M. Weston…·T. E. Morrison

This paper develops a phage-like particle vaccine platform that is immunogenic and protects against SARS-CoV-2 and MERS-CoV infection and disease.

DOI 10.1038/s41541-022-00481-1

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 9, 2021

An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice

F. Borriello, E. Nanishi, H.-S. Seo…·O. Levy

This study identifies an adjuvanted SARS-CoV-2 RBD nanoparticle that induces neutralizing antibodies and full protection in aged mice.

DOI 10.1101/2021.09.09.459664

mouseprotein structure

𝕏 PostBluesky

ImmunologybioRxivMay 20, 2021

Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity

E. Nanishi, F. Borriello, T. R. O'Meara…·D. J. Dowling

This study evaluates AH:CpG adjuvant's ability to enhance RBD vaccine efficacy in aged mice and human elder cells, showing strong neutralizing antibody responses and cytokine production.

DOI 10.1126/scitranslmed.abj5305

𝕏 PostBluesky